GYG Gyg Plc

RNS Number:5575P
Gyrus Group PLC
16 January 2007

16th January 2007

                                 Gyrus Group PLC

                           Pre-Close Period Statement


Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices which
reduce trauma and complications in surgery, today provides a pre-close period
update ahead of its preliminary results announcement on 16th March 2007.

The Group's reported revenues for the year to 31st December 2006 are anticipated
to be approximately #213 million representing growth of over 40% on the previous
year (2005: #150million). Proforma underlying revenue growth (assuming a full
comparative contribution from American Cystoscope Makers Inc ("ACMI"), on a
constant exchange rate basis and excluding discontinued business lines) is
expected to be approximately 7%, an improvement on the 6% growth shown in the
first half of the financial year. This was driven by a strong sales performance
in the last quarter of the year.

The integration of ACMI continued during the year in line with management's
expectations. The Group's new North American customer service and distribution
centre is up and running in Minnesota and the Racine, Wisconsin plant closure is
nearing completion. Additionally, the transfer of part of the Group's production
to the new Mexican plant has now commenced.

Subject to completion of the audit it is anticipated that Earnings per Share for
the year to 31st December 2006 will be in line with market expectations.

A large number of new products have been introduced to market in 2006; the most
significant being the PlasmaCision range in support of the Group's entry into
the large general surgery market. Total revenues from this range in 2006 were
approximately $7.6m ($4.6m disposable instruments and $3.0m G400 Generators)
compared with $2.8m ($1.9m disposable instruments and $0.9m G400 Generators) in
the first half of the year. Market feedback on this novel simultaneous "cut and
seal" technology has been very positive and the Surgical Division has installed
approximately 400 G400 generators into the US market, which comprises both
gynaecologists and general surgeons. The post market optimisation of the
PlasmaSeal instrument for open surgical procedures and improvements to the
PlasmaTrissector for laparoscopic procedures have progressed well. The
combination of the level of generator installations and the improvements to the
Group's two leading general surgery instruments represents a good platform for
2007.

Brian Steer, Executive Chairman of Gyrus said:

"In the crucial first full year of the combined Gyrus ACMI business we have
successfully made savings in the combined US organisation at the same time as
introducing a significant number of new products to market. Despite the
substantial fall in the value of the US dollar, our principal operating
currency, we have made good progress in the year and we look to continue the
Group's strong performance in 2007."


Enquiries:

Gyrus Group PLC
Brian Steer, Executive Chairman                          01189 219 750
Simon Shaw, Chief Financial Officer                      01189 219 750

Financial Dynamics
Ben Atwell                                               0207 831 3113



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCUVABRBVRAAAR

Gyg (LSE:GYG)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Gyg (LSE:GYG)
Historical Stock Chart
Von Jul 2023 bis Jul 2024